Cellanome
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- $150M
Investors
- 2
About Cellanome
Based in California, US, and founded in 2020, Cellanome, Inc. is a biotechnology company. In July 2022, Cellanome, Inc. The company was founded by Mostafa Ronaghi. Cellanome develops and offers an automated platform to study individual cells through sequencing, microfluidics, computational biology, and molecular biology. The platform provides a deeper understanding of how individual cells behave, interact, and function under various stimuli and conditions. The company allows researchers to study the behavior, interactions, and functions of individual cells.
Who invested in Cellanome
2 investors across 1 round
See all investors in Cellanome
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Dec 4, 2023
Amount
$150M
Investors
Questions about Cellanome
Who invested in Cellanome?
Cellanome has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellanome raised?
Cellanome has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cellanome last raise money?
Cellanome's most recent round on record is a Series B, in Dec 2023.
What does Cellanome do?
Based in California, US, and founded in 2020, Cellanome, Inc.
Where is Cellanome headquartered?
Cellanome is headquartered in Palo Alto, US.
Which VCs invest in companies like Cellanome?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cellanome's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cellanome? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.